Jaguar Health, Inc. JAGX
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$2.06$2.24
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -58.88% | 814.50% | -7.81% | -0.80% | 9.48% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -58.88% | 815.63% | -7.81% | -0.80% | 9.48% |
| Cost of Revenue | 95.64% | 124.85% | 294.97% | -1.66% | 23.42% |
| Gross Profit | -92.09% | 1,025.01% | -64.94% | -0.62% | 6.89% |
| SG&A Expenses | -38.07% | -32.29% | 8.96% | 5.96% | 23.23% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -19.70% | -13.28% | 102.96% | -0.47% | 10.77% |
| Operating Income | 5.12% | 208.08% | -150.61% | 0.33% | -11.25% |
| Income Before Tax | -21.23% | 182.32% | -126.63% | 3.72% | -9.68% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.23% | 182.32% | -126.63% | 3.72% | -9.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -21.57% | -4.55% | -57.96% | -12.57% | 12.50% |
| Net Income | -21.86% | 184.57% | -132.47% | 3.57% | -9.64% |
| EBIT | 5.12% | 208.08% | -150.61% | 0.33% | -11.25% |
| EBITDA | 5.38% | 219.16% | -159.99% | 0.43% | -11.54% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |